Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;225(1):220-3.
doi: 10.1016/j.atherosclerosis.2012.08.028. Epub 2012 Sep 1.

Protective role of clusterin in preserving endothelial function in AL amyloidosis

Affiliations

Protective role of clusterin in preserving endothelial function in AL amyloidosis

Daniel A Franco et al. Atherosclerosis. 2012 Nov.

Abstract

Misfolded immunoglobulin light chain proteins (LC) in light chain amyloidosis (AL) are toxic to vascular tissues. We tested the hypothesis that chaperone protein clusterin preserves endothelial function and cell survival during LC exposure.

Methods: LC (20 μg/mL) were given to human aortic endothelial cells (EC) for 24-h and clusterin protein/gene expression and secretion were measured. DNA fragmentation was measured with/without recombinant clusterin (Clu, 300 ng/mL). Adipose arterioles (non-AL subjects) were tested for dilator responses to acetylcholine/papaverine at baseline and after 1-h of LC ± Clu.

Results: LC reduced EC clusterin secretion, protein and gene expression while increasing DNA fragmentation. Clu attenuated LC-induced DNA fragmentation and restored dilator response to acetylcholine (logEC50: control -7.05 ± 0.2, LC + Clu -6.53 ± 0.4, LC -4.28 ± 0.7, p < 0.05 versus control, LC + Clu).

Conclusions: LC induced endothelial cell death and dysfunction while reducing clusterin protein/gene expression and secretion. Exogenous clusterin attenuated LC toxicity. This represents a new pathobiologic mechanism and therapeutic target for AL amyloidosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Endothelial cell clusterin. A. LC reduced precursor/secreted clusterin production (insert is Western blot), clusterin mRNA production (B) and secreted clusterin (C). D. LC increased EC cell death that was attenuated with clusterin co-treatment.
Figure 2
Figure 2
Light chain proteins and arterioles. A–B. LC impaired dilator response to acetylcholine and papaverine. Co-treatment with clusterin attenuated adverse effect of LC and restored acetylcholine EC50. L-NAME blunted the protective effect of clusterin. C–D. LC reduced 30-minute NO production and increased peroxynitrite production in arterioles; clusterin protected against these changes.

Similar articles

Cited by

References

    1. Greene MJ, Sam F, Soo Hoo PT, Patel RS, Seldin DC, Connors LH. Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy. Am J Pathol. 178:61–68. - PMC - PubMed
    1. Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM. Plasma clusterin and the risk of Alzheimer disease. JAMA. 305:1322–1326. - PubMed
    1. Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM, Wilson MR. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J. 2007;21:2312–2322. - PubMed
    1. Migrino RQ, Truran S, Gutterman DD, Franco DA, Bright M, Schlundt B, Timmons M, Motta A, Phillips SA, Hari P. Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins. Am J Physiol Heart Circ Physiol. 2011;301:H2305–2312. - PMC - PubMed
    1. Berghoff M, Kathpal M, Khan F, Skinner M, Falk R, Freeman R. Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis. Ann Neurol. 2003;53:725–730. - PubMed

Publication types